Wang, Y., Zheng, S., Gao, Y., Zhu, Y., Sun, P., Luo, S., Luo, Z., Chen, Z., Chen, J., Cai, X., He, Y., Ma, M., Yu, Y., Jin, S., Lan, D., Chen, Y. (2025). Sintilimab in combination with cetuximab and chemotherapy as first-line treatment for RAS/BRAF wild-type advanced colorectal cancer (CALLIOPSIS): An open-label, non-comparative, phase 1b/2 dose escalation and expansion trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15531